Cryoport Inc (NASDAQ: CYRX) has entered into a strategic partnership with Worthington Industries (NYSE: WOR), maker of cryogenic storage vessels and equipment. Through this partnership, Worthington’s CryoScience by Taylor Wharton business will design and manufacture biostorage and logistics equipment for use in Cryoport’s life sciences cryogenic logistics solutions.
Proprietary cold chain logistics solutions from Cryoport protect frozen life sciences commodities from adverse thermal excursions during clinical development through commercial manufacture. This contributes to increased success in transport and storage and efficacy. Through its recently acquired CryoScience by Taylor Wharton product line, Worthington manufactures cold chain storage and transport vessels and equipment that provide critically reliable transportation of biological commodities.
As a leading provider of cold chain logistics solutions to the life sciences industry, Cryoport is committed to further enhancing its proprietary shippers, information technology, and specialized cold chain logistics expertise to continue differentiating its services and providing value to clients. This partnership also allows Cryoport to expand into other logistics areas such as storage.
“Working in tandem with Worthington’s CryoScience by Taylor-Wharton team allows Cryoport to meet the demands of a more diverse clientele through a broader offering which in turn, increases our revenue opportunity as well as provides us the opportunity to rapidly scale to support our clients’ commercialization activities,” said Mark Sawicki, chief commercial officer of Cryoport.
For more information, see www.cryoport.com.